Literature DB >> 17337600

Dual cardiac contractile effects of the alpha2-AMPK deletion in low-flow ischemia and reperfusion.

Karla Carvajal1, Elham Zarrinpashneh, Ondrej Szarszoi, Frederic Joubert, Yoni Athea, Philippe Mateo, Brigitte Gillet, Sophie Vaulont, Benoit Viollet, Xavier Bigard, Luc Bertrand, Renée Ventura-Clapier, Jacqueline A Hoerter.   

Abstract

Because the question "is AMP-activated protein kinase (AMPK) alpha(2)-isoform a friend or a foe in the protection of the myocardium against ischemia-reperfusion injury?" is still in debate, we studied the functional consequence of its deletion on the contractility, the energetics, and the respiration of the isolated perfused heart and characterized the response to low-flow ischemia and reperfusion with glucose and pyruvate as substrates. alpha(2)-AMPK deletion did not affect basal contractility, respiration, and high-energy phosphate contents but induced a twofold reduction in glycogen content and a threefold reduction in glucose uptake. Low-flow ischemia increased AMPK phosphorylation and stimulated glucose uptake and phosphorylation in both alpha(2)-knockout (alpha(2)-KO) and wild-type (WT) groups. The high sensitivity of alpha(2)-KO to the development of ischemic contracture was attributed to the constitutive impairment in glucose transport and glycogen content and not to a perturbation of the energy transfer by creatine kinase (CK). The functional coupling of MM-CK to myofibrillar ATPase and the CK fluxes were indeed similar in alpha(2)-KO and WT. Low-flow ischemia impaired CK flux by 50% in both strains, showing that alpha(2)-AMPK does not control CK activity. Despite the higher sensitivity to contracture, the postischemic contractility recovered to similar levels in both alpha(2)-KO and WT in the absence of fatty acids. In their presence, alpha(2)-AMPK deletion also accelerated the contracture but delayed postischemic contractile recovery. In conclusion, alpha(2)-AMPK is required for a normal glucose uptake and glycogen content, which protects the heart from the development of the ischemic contracture, but not for contractile recovery in the absence of fatty acids.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17337600     DOI: 10.1152/ajpheart.00683.2006

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  36 in total

1.  AMPK protects proximal tubular cells from stress-induced apoptosis by an ATP-independent mechanism: potential role of Akt activation.

Authors:  Wilfred Lieberthal; Leiqing Zhang; Vimal A Patel; Jerrold S Levine
Journal:  Am J Physiol Renal Physiol       Date:  2011-09-28

Review 2.  KATP Channels in the Cardiovascular System.

Authors:  Monique N Foster; William A Coetzee
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

3.  The vestigial enzyme D-dopachrome tautomerase protects the heart against ischemic injury.

Authors:  Dake Qi; Kwame Atsina; Lintao Qu; Xiaoyue Hu; Xiaohong Wu; Bin Xu; Marta Piecychna; Lin Leng; Günter Fingerle-Rowson; Jiasheng Zhang; Richard Bucala; Lawrence H Young
Journal:  J Clin Invest       Date:  2014-07-01       Impact factor: 14.808

Review 4.  AMP-activated protein kinase regulation and biological actions in the heart.

Authors:  Vlad G Zaha; Lawrence H Young
Journal:  Circ Res       Date:  2012-08-31       Impact factor: 17.367

5.  AMPKβ1 and AMPKβ2 define an isoform-specific gene signature in human pluripotent stem cells, differentially mediating cardiac lineage specification.

Authors:  Nicole Ziegler; Erik Bader; Alexey Epanchintsev; Daniel Margerie; Aimo Kannt; Dieter Schmoll
Journal:  J Biol Chem       Date:  2020-10-16       Impact factor: 5.157

Review 6.  Translating cell survival and cell longevity into treatment strategies with SIRT1.

Authors:  K Maiese; Z Z Chong; Yan Chen Shang; S Wang
Journal:  Rom J Morphol Embryol       Date:  2011       Impact factor: 1.033

7.  Impact of caloric restriction on myocardial ischaemia/reperfusion injury and new therapeutic options to mimic its effects.

Authors:  Susanne Rohrbach; Muhammad Aslam; Bernd Niemann; Rainer Schulz
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

Review 8.  Targeting cardiovascular disease with novel SIRT1 pathways.

Authors:  Zhao Zhong Chong; Shaohui Wang; Yan Chen Shang; Kenneth Maiese
Journal:  Future Cardiol       Date:  2012-01

9.  AMP-activated protein kinase deficiency enhances myocardial ischemia/reperfusion injury but has minimal effect on the antioxidant/antinitrative protection of adiponectin.

Authors:  Yajing Wang; Erhe Gao; Ling Tao; Wayne Bond Lau; Yuexin Yuan; Barry J Goldstein; Bernard L Lopez; Theodore A Christopher; Rong Tian; Walter Koch; Xin-Liang Ma
Journal:  Circulation       Date:  2009-02-02       Impact factor: 29.690

10.  AMPK is critical for mitochondrial function during reperfusion after myocardial ischemia.

Authors:  Vlad G Zaha; Dake Qi; Kevin N Su; Monica Palmeri; Hui-Young Lee; Xiaoyue Hu; Xiaohong Wu; Gerald I Shulman; Peter S Rabinovitch; Raymond R Russell; Lawrence H Young
Journal:  J Mol Cell Cardiol       Date:  2015-12-30       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.